Author:
Fukui Masao,Kawaguchi Kohei,Matsuura Hiroaki
Abstract
In the middle of the global COVID-19 pandemic, the BCG hypothesis, the prevalence and severity of the COVID-19 outbreak seems to be correlated with whether a country has a universal coverage of Bacillus-Calmette-Guérin (BCG), a vaccine for tuberculosis disease (TB), has emerged and attracted the attention of scientific community and media outlets. However, all existing claims are based on cross-country correlations that do not exclude the possibility of spurious correlation. We merged country-age-level case statistics with the start/termination years of BCG vaccination policy and conducted a regression discontinuity and difference-indifference analysis. The results do not support the BCG hypothesis.
Publisher
Cold Spring Harbor Laboratory
Reference15 articles.
1. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection
2. Bloomberg. March-30-2020. “Coronavirus: 100-Year-Old Vaccine Tested as Virus Weapon.” https://www.bloomberg.com/news/articles/2020-03-30/century-old-vaccine-investigated-as-a-weapon-against-coronavirus.
3. Giovanni Sala , and Tsuyoshi Miyakawa . 2020. “Association of BCG Vaccination Policy with Prevalence and Mortality of COVID-19.” Preprint.
4. The National Childhoold Immunization Programmes in Singapore;Singapore Medical Journal,1985
5. Thirty Years of Vaccination in Vietnam: Impact and Cost-Effectiveness of the National Expanded Programme on Immunization;Vaccine,2015
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献